School of Medicine

A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Washington University School of Medicine in St. Louis and BJC Health System have launched the joint Center for Health AI. The center will focus on making care more personalized and effective for patients and more efficient and manageable for physicians, nurses and all those striving to ensure patients receive the best care.

Andrew Yoo, a professor of developmental biology at WashU Medicine, has received the 2024 Transformative Research Award, a two-year $1 million grant from the Hereditary Disease Foundation.

Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.

Researchers at WashU Medicine collaborated with an international team of doctors and scientists to identify the cause of a rare genetic disorder involving intellectual disability and brain malformations.

Sheng Chih (Peter) Jin, an assistant professor of genetics at WashU Medicine, has received a $3.2 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.

Four WashU faculty members were named Distinguished Investigators by the Academy for Radiology & Biomedical Imaging Research.

Researchers at WashU Medicine have found a process in which the brain guards against attack by the immune system, opening opportunities to pursue new therapies for diseases such as multiple sclerosis and Alzheimer’s.

A new analysis led by WashU Medicine researchers has revealed detailed 3D maps of the internal structures of multiple tumor types. These maps could lead to new approaches to therapy.

Guoyan Zhao, PhD, and Erik Musiek, MD, PhD, both at WashU Medicine, have received a $433,000 grant from the National Institute on Aging of the National Institutes of Health (NIH) to study brain cells called astrocytes and their roles in neurodegenerative diseases, including Alzheimer’s and Parkinson’s.